Ketone Monitoring for Type 1 Diabetes
(KARMA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research is to see how well a special education plan using continuous ketone monitoring (DGK) works to lower the risk of a condition called diabetic ketoacidosis (DKA) in people with type 1 diabetes (T1D) taking SGLT2 inhibitors (a type of medication commonly used to treat type 2 diabetes). This special education plan is compared to a general education plan and considers the higher risk of DKA when using medicines like SGLT2 inhibitors.
Who Is on the Research Team?
Richard Pratley, MD
Principal Investigator
AdventHealth
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Education and Monitoring
Participants receive a special education plan using continuous ketone monitoring to mitigate DKA risk
Follow-up
Participants are monitored for safety and effectiveness after the education and monitoring phase
What Are the Treatments Tested in This Trial?
Interventions
- Sotagliflozin
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
AdventHealth Translational Research Institute
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.